Adults in Germany should be able to get the vaccine from the American company Novavax, advises the STIKO vaccination committee.
Because this vaccine works differently from the means used so far, it can convince people who have not yet been vaccinated, the idea is.
The vaccine called Nuvaxovid is the fifth corona vaccine that can be used in Europe. It is based on proteins, a proven technique. In the Netherlands, it is expected to be used in the course of March.
The German committee also recommends that a booster shot should be given with a so-called mRNA vaccine, such as that of BioNTech/Pfizer or Moderna.
Such an agent should also be used for a second booster shot. The recommendation is that vulnerable groups and healthcare staff get such a second boost as soon as they are eligible for it.